News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Smith Jason Drew
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 409 shares
@ $10.12, valued at
$4.1k
Sold 1,227 shares
@ $10.12, valued at
$12.4k
Exercised 833 restricted stock units
@ $0
Exercised 2,500 restricted stock units
@ $0
Granted 20,000 restricted stock units
@ $0
Granted 40,000 options to buy
@ $10.39, valued at
$415.6k
|
|
| 09/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 414 shares
@ $7.58, valued at
$3.1k
Exercised 833 restricted stock units
@ $0
Granted 7,500 restricted stock units
@ $0
Granted 30,000 options to buy
@ $7.72, valued at
$231.6k
|
|
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2020 |
4/A
| Smith Jason Drew (General Counsel) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 60,000 options to buy
@ $19.66, valued at
$1.2M
Granted 25,000 restricted stock units
@ $0 |
|
|
|